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Objective: Dietary proteins are sensed by hypothalamic neurons and strongly influence multiple aspects of metabolic health, including appetite,
weight gain, and adiposity. However, little is known about the mechanisms by which hypothalamic neural circuits controlling behavior and
metabolism sense protein availability. The aim of this study is to characterize how neurons from the mediobasal hypothalamus respond to a signal
of protein availability: the amino acid L-leucine.
Methods: We used primary cultures of post-weaning murine mediobasal hypothalamic neurons, hypothalamic neurons derived from human
induced pluripotent stem cells, and calcium imaging to characterize rapid neuronal responses to physiological changes in extracellular L-Leucine
concentration.
Results: A neurochemically diverse subset of both mouse and human hypothalamic neurons responded rapidly to L-leucine. Consistent with L-
leucine’s anorexigenic role, we found that 25% of mouse MBH POMC neurons were activated by L-leucine. 10% of MBH NPY neurons were
inhibited by L-leucine, and leucine rapidly reduced AGRP secretion, providing a mechanism for the rapid leucine-induced inhibition of foraging
behavior in rodents. Surprisingly, none of the candidate mechanisms previously implicated in hypothalamic leucine sensing (KATP channels,
mTORC1 signaling, amino-acid decarboxylation) were involved in the acute activity changes produced by L-leucine. Instead, our data indicate that
leucine-induced neuronal activation involves a plasma membrane Ca2þ channel, whereas leucine-induced neuronal inhibition is mediated by
inhibition of a store-operated Ca2þ current.
Conclusions: A subset of neurons in the mediobasal hypothalamus rapidly respond to physiological changes in extracellular leucine concen-
tration. Leucine can produce both increases and decreases in neuronal Ca2þ concentrations in a neurochemically-diverse group of neurons,
including some POMC and NPY/AGRP neurons. Our data reveal that leucine can signal through novel mechanisms to rapidly affect neuronal
activity.
 2018 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Dietary proteins strongly influence metabolic health via their effect on
appetite, weight gain, and adiposity [1e3]. Compelling evidence in-
dicates that protein is the macronutrient that has the largest impact on
energy intake, and that protein intake is tightly regulated independently
of fat, carbohydrate, and energy intake [1,4]. Several peripheral sig-
nals, including gut peptides and FGF21 [5e7], have been implicated in
protein-induced satiety. However, none of these peptides specifically
signal protein availability, suggesting that additional protein-specific
mechanisms are involved to allow a tight, fat- and carbohydrate-
independent regulation of protein intake.MRC Metabolic Diseases Unit, University of Cambridge Metabolic Research Laboratorie
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to represent a physiological signal of protein availability in the control of
appetite and metabolism. In humans and rodents, circulating leucine
levels rapidly increase following the ingestion of a protein dense meal
[8e10], and consumption of a protein-diluted diet chronically reduces
serum leucine levels [11]. It is well documented in the literature that
leucine signals protein abundance to regulate key anabolic functions
including muscle protein synthesis [12] and beta-cell insulin release
[13] at least in part via mTORC1 signaling, a pathway for which leucine
is the main activator [14]. Importantly, protein sources with higher
anabolic value (assessed by their ability to promote growth or activate
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increased satiety in flies [15], rodents [16], and humans [8], reinforcing
the idea that blood leucine levels may convey information about the
anabolic value of the meal to regulate appetite. In addition, leucine
supplementation is sufficient to produce satiety in healthy humans [17].
Signals encoding protein availability, including leucine, likely act on the
brain to control energy balance. The brain rapidly senses and responds
to changes in circulating leucine levels during nutritional transitions
[10]. Appetite-regulating neurons in the arcuate nucleus of the hypo-
thalamus (ARH) are well positioned to sense changes in leucine levels
and engage downstream neuroendocrine and behavioral neural cir-
cuits. Located in the vicinity of the median eminence, they are directly
exposed to circulating nutrient levels during energy deprivation [18],
and project neural processes to the median eminence parenchyma,
allowing constant monitoring of blood-borne signals [19]. Local
nanoinjection of leucine into the MBH produces satiety. Remarkably,
this response includes a rapid delay in meal initiation and reduction of
meal size, indicating that leucine can acutely alter the activity of
orexigenic and anorexigenic circuits [10]. However, the molecular,
neurophysiological and neurochemical mechanisms implicated in this
rapid change in feeding behavior remain poorly understood.
In this study, we aimed to characterize the neurophysiological re-
sponses of mediobasal hypothalamic neurons to physiological changes
in extracellular leucine levels, test leucine responsiveness of POMC
and non-POMC MBH neuronal subsets, and investigate the mecha-
nisms involved in rapid leucine detection. In order to observe rapid,
cell-autonomous responses to leucine in multiple species, we per-
formed our studies in freshly dissociated mouse MBH neurons as well
as human pluripotent stem cell (hPSC)-derived hypothalamic neurons.
2. MATERIALS AND METHODS
2.1. Mice
All mice were group-housed and maintained in individually ventilated
cages with standard bedding and enrichment. Mice were housed in a
temperature and humidity-controlled room on a 12-h light/dark cycle
with ad libitum access to water and standard laboratory chow diet
unless otherwise stated. C57/Bl6J males were obtained from Charles
River UK. NPY-GFP mice (Jackson Labs Stock No: 006417) were
genotyped with the following primers: 50-TATGTGGACGGGGCAGAAG
ATCCAGG-30; 50-CCCAGCTCACAT ATTTATCTAGAG-30; 50-GGTGCGGTT
GCCGTACTGGA-30. POMC-GFP mice (Jackson Labs Stock No 009593)
were genotyped using the following primers: 50-AAGTTCATCTGCACC
ACC G-30; 50-TCCTTGAAGAAGATGGTG CG-30. All studies were
approved by the local Ethics Committee and conducted according to
the UK Home Office Animals (Scientific Procedures) Act 1986.
2.2. Primary culture of post-weaning mediobasal hypothalamic
neurons
Primary cultures of mediobasal hypothalamic neurons were prepared
from 4 to 6-week old C57/Bl6J, POMC-EFGP, and NPY-GFP males
fasted overnight. Throughout the extraction and culture process, all
media contained physiologically relevant concentrations of glucose and
amino acids, based on concentrations measured in rat cerebrospinal
fluid and microdialysis extracts [10,20,21]. Mice were killed by cervical
dislocation. Brains were extracted and rapidly placed into ice-cold
extraction media (Supplementary Table 1). For each brain, 2 brain
sections of 0.75 mm were cut using a McIlwain tissue chopper,
starting 1.2 mm post the anterior commissure and ranging
from 1.06 mm post Bregma to 2.54 mm post Bregma [22]. The
MBH was then dissected from coronal slices by using a magnifying
loupe and cutting out an equilateral triangle containing the ventral halfMOLECULAR METABOLISM 10 (2018) 14e27  2018 The Authors. Published by Elsevier GmbH. This is an
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was transferred to papain (20 U/ml, Worthington, Lakewood, NJ, USA)
pre-heated at 37 C and digested for 30 min at 37 C under agitation
(Thermomixer, 500 rpm). After digestion, tissue extracts from 6 to 7
animals were pooled, transferred to a tube containing extraction media
with 3.5 U/ml DNase I from bovine pancreas (Sigma) using a glass
Pasteur pipette with a fire polished 1.5 mm opening, and triturated
with pipettes with decreasing diameters (prepared according to Nagy
et al., 2006). The trituration supernatant was gently loaded on top of a
BSA gradient (4% BSA prepared in extraction media (pH 7.4) loaded on
top of 8% BSA (pH 7.4)), spun for 5 min at 300 rcf, and the pellet was
resuspended in culture media. 100 ml of resuspended cells were
plated on the glass portion of 35 mm dishes (MatTek Corporation),
coated with poly-lysine (0.1 mg/ml) using a 0.5 mm trituration pipette,
inside a cloning cylinder (8 mm2, Sigma). Plates were placed in an
incubator (37 C, 5% CO2) for 1 h. After 1 h, an additional 2 ml culture
media was added and the cloning cylinder removed. 4 to 6 culture
dishes were prepared on each experimental day. Each culture dish was
imaged once and represented our experimental unit.
For longer cell maintenance, 0.3 nM FGF2 (Sigma) was added to the
culture media and media was changed every 2 days.
2.3. Calcium imaging (adapted from [23])
Cells were loaded with 5 mM Fura2 AM dye (Life Technologies) for
30 min, washed with aCSF (supplemented with amino acids and
glucose, see Supplementary methods), and imaged using an inverted
fluorescence microscope (Olympus IX71, Olympus, Southend on Sea,
UK) with a 40 oil-immersion objective lens. GFP (to identify POMC or
NPY cells) was excited at 488 nm and fura-2 at 340 nm and 380 nm
using a monochromator (Cairn Research, Faversham, UK) and a 75 W
xenon arc lamp, and emissions were recorded using an Orca ER
camera (Hamamatsu, Welwyn Garden City, UK), a dichroic mirror and a
510 nm long pass filter. All images were collected on MetaFluor
software (Molecular Devices, Wokingham, UK). The ratio of fura-2
emissions at 340 and 380 nm (340/380 ratio) was used to monitor
changes in the intracellular calcium concentration. Solutions were
perfused continuously at a rate of approximately 0.5 ml/min.
2.4. Immunofluorescent staining
Murine primary cultures were fixed with 4% PFA, washed 3 times in
0.1% PBST, followed by blocking in 5% normal donkey serum in 0.3%
PBST. Primary antibody, mouse anti-NeuN (1:250, Millipore), chicken
anti-MAP2 (1:500, Abcam) or rabbit anti-Ser235/236 rpS6 (1:1000,
Cell Signaling Technologies) was applied overnight at 4 C. After PBS
wash, secondary antibody in 5% normal donkey serum, was applied
for 1 h. After PBS wash, Vectashield with DAPI (Vector Labs) was
added to coverslips inverted onto SuperFrost Plus slides. We analyzed
fluorescence colocalization to evaluate the number of neurons using
confocal microscopy and ImageJ (NIH).
For hPSC cells immunostaining, cells were fixed in 4% w/v para-
formaldehyde in PBS for 10 min at room temperature. After three
washes in TBS, cultures were incubated overnight at 4 C with anti-
POMC primary antibody (1:1,000, Abcam ab14064) diluted in 10%
normal donkey in TBS with 0.1% Triton X-100, and then washed three
times in TBS. Cells were then incubated in Alex Fluor-conjugated
secondary antibodies (Thermo Fisher Scientific) diluted 1:500 in
10% normal donkey in TBS with 0.1% Triton X-100 for 2 h at room
temperature. After three washes in TBS, cells were incubated in
360 nM DAPI in TBS, washed a further three times in TBS, and imaged
on a Zeiss LSM 510 confocal microscope. Images were analyzed and
processed with ImageJ (NIH).open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 15
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Trypan Blue staining was performed 24 h post plating. Trypan blue
(0.2%, filtered, Sigma) was added to each well for 15 min followed by
washing 3 times with PBS. Cells were visualized by Brightfield mi-
croscopy on an Evos XL Core Cell Imaging System (Life Technologies).
Images were processed using ImageJ and counted to assess the
number of live neurons, dead neurons, and the amount of debris.
2.6. Human derived hypothalamic neurons
Human pluripotent stem cells (hPSCs) (13B iPSC) were maintained in
mTESR1 media [24] and differentiated to hypothalamic neurons as
previously described [25,26]. Human hypothalamic neurons were used
at 30e50 days in vitro, at which point there were abundant neurons
immunoreactive for POMC. To study cell-autonomous responsiveness
to L-leucine, cultures were enzymatically dissociated with TrypLE and
Papain as described previously (Kirwan, Jura et al., 2017) and replated
onto glass-bottomed 35 mm dishes (MatTek Corporation) coated with
Geltrex (Thermo Fisher Scientific, 21041025). Cells were loaded with
5 mM Fura2 AM for 45 min and treated with vehicle or experimental
solutions as described above.
2.7. AGRP secretion from medial hypothalamic slices
The release of AGRP from mouse hypothalamic slices was measured
ex vivo as described by Enriori et al. [27]. Extraction and culture media
described in Supplementary methods and supplemented with
0.6 TIU aprotinin/ml were used. 2 mm medial hypothalamic slices
containing the PVH and ARH were prepared from C57/Bl6J mice in ice-
cold extraction media. Slices were equilibrated for 1 h at 37C in culture
media. Culture supernatant was collected following a 45-minutes with
incubation in 300 ml culture media, a 45 min incubation with culture
media þ500 mM Leu, and a final 45 min incubation with culture
media þ56 mM KCL. AGRP levels were measured using an ELISA kit
from Phoenix Pharmaceuticals.
2.8. Drugs used
10000 stocks of thapsigargin (2 mM, Sigma), Rapamycin (100 mM,
Millipore), Ryanodine (250 mM, Insight Biotechnology) and 2-APB
(1 M, Abcam) were prepared in DMSO. 200 stocks of tolbumatide
(100 mM, Sigma) and Diazoxide (68 mM, Sigma) were prepared as in
1 M Sodium Hydroxide, which was neutralized in final solution using an
equivalent volume of 1 M HCl. BCH (2-amino-2-nobornanecarboxylic
acid, Sigma), L-leucine, KIC and L-valine (Sigma) were prepared in
the aCSF solution used for imaging.
2.9. Data and statistical analysis
Treatments were randomly assigned to each culture dish and relevant
control conditions were systematically included on each experimental
day. For each culture dish (experimental unit), imaging data from all
cells within the 40 objective visual field were analyzed using stan-
dardized criteria for all our imaging experiments, allowing unbiased
analysis. Data were smoothed using the sliding window method
over 20 s. From these smoothed data, we calculated for each control
and treatment periods 1 e the area under the curve (AUC) over 8 min
for 10 min exposure periods, excluding the first and last minute of
each period, or over 4 min for 5 min exposure periods, excluding the
first and last 30 s of each period, 2 e the maximum Fura2 340/380
ratio, 3 e the minimum Fura2 340/380 ratio and 4 e the mean Fura2
340/380 ratio over 4 min or 8 min.
To determine whether a cell was activated or inhibited, we used an
Excel macro combining a number of criteria as follows. Only cells
showing a calcium response to KCl (max Fura2 340/380 ratio during16 MOLECULAR METABOLISM 10 (2018) 14e27  2018 The Authors. Published by Elsevier GKCl treatment at least 50% higher than baseline Fura2 340/380 ratio)
and with a Fura2 340/380 ratio stable throughout baseline and
washout periods (average Fura2 340/380 ratio during washout
maximum 10% higher or lower than average Fura2 340/380 ratio at
baseline) were included in the analysis. Cells were considered acti-
vated if showing a reversible increase in Fura2 340/380 ratio during
the treatment period, with AUC of the Fura2 340/380 ratio during the
treatment period at least 15% higher than during both vehicle treat-
ment periods. Cells were considered inhibited if showing a reversible
decrease in Fura2 340/380 ratio during the treatment period, with the
AUC of the Fura2 340/380 ratio during the treatment period at least
10% lower than during both vehicle treatment periods. These
thresholds were empirically determined by testing different threshold
levels and comparing the activation status obtained with the excel
macro (activated, inhibited, or no effect) to the activation status
determined visually (inspecting calcium traces) by 2 blinded individuals
on around 250 neurons. Subsequently, all traces were visually
inspected to confirm the validity of the analysis.
All data, presented as means  SEM, have been analyzed using
GraphPad Prism 6. For all statistical tests, an a risk of 5% was used.
All dataset with multiple treatments were analyzed using repeated-
measures two-way ANOVAs and adjusted with Bonferroni’s post hoc
tests.
Multiple comparisons were tested with one-way ANOVAs and adjusted
with Tukey’s post hoc tests. Single comparisons were made using
one-tail Student’s t tests.
3. RESULTS
3.1. Culture of post-weaning mouse mediobasal hypothalamic
neurons
To characterize the acute cell-autonomous neurophysiological re-
sponses of murine mediobasal hypothalamic neurons to physiological
changes in extracellular leucine levels and investigate the molecular
and neurochemical underpinnings, we first optimized calcium imaging
of freshly dissociated mouse mediobasal hypothalamic (MBH) neurons.
We used mice between 4- to 6-weeks of age to investigate leucine-
sensing properties of post-weaning MBH neurons. We optimized a
culture protocol based on the published literature [28,29] (Figure 1A)
(Supplementary Figure 1). Commercially available neuronal culture
media contain supra-physiological concentrations of glucose and
amino acids, preventing the study of how physiological changes in
nutrient concentrations are sensed by neurons. We therefore produced
our own extraction and culture media with physiological nutrient
concentrations based on those measured in rat cerebrospinal fluid and
hypothalamic microdialysis extracts (see Material and Methods)
[10,20]. These media did not affect cellular yield and viability
(assessed by trypan blue staining on neurons up to 3 days in culture)
compared to cultures prepared with Hibernate A (BrainBits) and
Neurobasal A (Invitrogen) (Supplementary Figure 1b).
As expected [29], cells in culture were predominantly neuronal and
expressed MAP2 and NeuN (Figure 1B,C). We assessed the respon-
siveness of these cultures to glucose and leptin, two metabolic sig-
nals sensed by mediobasal hypothalamic neurons. We found that a
transition from 2.5 mM to 5 mM glucose triggered an increase in
intracellular Ca2þ concentration [Ca2þ]i in 25% of neurons in culture,
and a decrease in [Ca2þ]i in 4.75% of neurons (Figure 1DeF),
consistent with previous observations [30,31]. 10 nM Leptin
increased [Ca2þ]i in 15% of neurons, and decreased [Ca2þ]i in 6.7%
of neurons, consistent with previous reports (Figure 1GeI) [32]. These
data indicate that under these culture conditions, dissociated MBHmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1: Primary culture of dissociated post-weaning mediobasal hypothalamic neurons sense glucose and leptin. Protocol to prepare dissociated mouse mediobasal
hypothalamic neurons for primary culture and calcium imaging (A). MAP2 (B) and NeuN (C) immunostaining in primary culture of mediobasal hypothalamic neurons. Glucose-
induced (D, E, F) and leptin-induced (G, H, I) calcium responses, assessed via 340/380 nm fluorescence ratios (reflecting [Ca2þ]i), in mouse mediobasal hypothalamic neu-
rons in culture exposed to a transition from 2.5 mM to 5 mM glucose or to 10 nM leptin. Data are means  SEM.neurons from post-weaning mice can survive and maintain metabolic
sensing properties.
3.2. Leucine rapidly alters [Ca2þ]i in a subset of mediobasal
hypothalamic neurons
We then went on to assess changes in [Ca2þ]i in response to a
10 min exposure to 500 mM leucine, a concentration consistent with
the physiological range of postprandial circulating leucine levels
(Blouet, 2009). Cells were exposed to a custom-made aCSF mediaMOLECULAR METABOLISM 10 (2018) 14e27  2018 The Authors. Published by Elsevier GmbH. This is an
www.molecularmetabolism.comcontaining low nutrient levels (see Supplementary methods) during
the first 10 min baseline period as well as during the 10e20 min
treatment period in control wells exposed to vehicle only. Treatment
with aCSF induced calcium responses in a small fraction of cells
(<3%, comparing [Ca2þ]I following treatment with aCSF compared to
the baseline period) (Figure 2A). Treatment with leucine produced
elevated [Ca2þ]i in 9% of neurons in culture (leucine-activated neu-
rons) and a decrease in [Ca2þ]i in 14% of neurons in culture (leucine-
inhibited neurons) (Figure 2AeC). Leucine-inhibited neurons wereopen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 17
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Figure 2: Leucine rapidly alters [Ca2D]i in a neurochemically-diverse subset of mouse mediobasal hypothalamic neurons. Leucine-induced changes in [Ca
2þ]i (A, B, C) as
assessed by 340/380 nm fluorescence ratios in primary cultures of mediobasal hypothalamic neurons. Peak 340/380 nm ratio (D) and 340/380 nm ratio AUC (E) during aCSF or
leucine exposure in leucine-activated neurons. Minimum 340/380 nm ratio (F) and 340/380 nm ratio AUC (G) during aCSF or leucine exposure in leucine-inhibited neurons. Calcium
responses to leucine in primary cultures of mediobasal hypothalamic POMC-GFP neurons (H). Leucine-induced changes in [Ca2þ]i (I, J) as assessed by 340/380 nm fluorescence
ratios in POMC-GFP neurons in culture. Calcium responses to leucine in primary cultures of mediobasal hypothalamic NPY-GFP neurons (K). Leucine-induced changes in [Ca2þ]i (L)
as assessed by 340/380 nm fluorescence ratios in NPY-GFP neurons in culture. AGRP secretion from 1 mm medial hypothalamic slices from fasted (n ¼ 11) or fed (n ¼ 10)
animals exposed to leucine (M). Data are means  SEM. *:p < 0.05. **: p < 0.01.
Original Articleactive during the baseline low-nutrient condition period, as indicated
by the higher baseline [Ca2þ]i during vehicle exposure compared to
leucine-activated neurons (Figure 2B,C,E,G). In activated cells, leucine
produced a peak in the Fura2 340/380 ratio 46% above that seen in
vehicle treated cells, and a 48% increase in the Fura2 340/380 AUC
(Figure 2D,E). In inhibited cells, leucine produced an average 61%18 MOLECULAR METABOLISM 10 (2018) 14e27  2018 The Authors. Published by Elsevier Gdecrease in Fura2 340/380 AUC (Figure 2F,G). These data indicate
that leucine can activate or inhibit subsets of mediobasal hypotha-
lamic neurons and that a total of 23% of mediobasal hypothalamic
neurons are primary leucine sensors. By contrast, 500 mM valine
activated only 2.7% and inhibited 0.4% of neurons in culture (n ¼ 4,
225 neurons).mbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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3.3. Leucine is rapidly sensed by MBH POMC and NPY neurons
We characterized leucine responses of MBH POMC and NPY neurons
using cultures obtained from POMC-EGFP and NPY-hrGFP mice.
Leucine activated 22% of POMC-EGFP neurons and inhibited 10% of
POMC-EGFP neurons (Figure 2HeJ). By contrast, only a small fraction
of NPY-GFP neurons were activated by leucine and 14% of NPY-GFP
neurons were inhibited by leucine (Figure 2K,L). To further establish
the ability of leucine to inhibit ARH NPY/AGRP neurons, we measured
AGRP secretion from hypothalamic sections maintained ex vivo with or
without leucine. Leucine failed to alter AGRP secretion from sections
obtained from fed animals. By contract, leucine significantly sup-
pressed AGRP secretion from hypothalamic sections obtained from
fasted animals (Figure 2M). Thus, subsets of POMC and NPY neurons
are leucine responsive, and, while leucine can either activate or inhibit
these two neuronal subpopulations, a majority of leucine-sensing
POMC neurons are activated by increased leucine concentrations,
and a majority of leucine-sensing NPY neurons are inhibited by
increased leucine concentrations.A
C
B
Figure 3: Leucine-induced changes in [Ca2D]i are independent of mTORC1 signaling
in primary cultures of mediobasal hypothalamic neurons treated for 1 h with 10 nM rapam
neurons pre-treated with rapamycin (B). Leucine-induced changes in [Ca2þ]i as assesse
neurons treated with rapamycin (C, D). Data are means  SEM.
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mTORC1 signaling
The mTORC1 signaling pathway is the best-characterized intracellular
leucine sensing pathway and has been implicated in MBH leucine
sensing and the anorectic effects of hypothalamic leucine exposure [33].
Treatment of mouseMBH primary cultures with 10 nM rapamycin for 1 h
suppressed S6 ribosomal Ser240/244 phosphorylation, a surrogate
marker for mTORC1 activity (Figure 3A). Under these conditions, we
found that leucine was still able to produce neuronal activation and
inhibition, at frequencies similar to those measured during exposure to
vehicle control (Figure 3BeD;main effect of Rapamycin: NS; main effect
of Leu: P ¼ 0.01; interaction: NS). Thus, rapid changes in [Ca2þ]i in
response to leucine inMBHneurons do not rely on activation ofmTORC1.
3.5. Rapid sensing of leucine by MBH neurons is independent of
leucine intracellular metabolism and KATP channels
ATP production and closure of KATP channels have been implicated in
nutrient sensing in pancreatic beta-cells and activation of mediobasalD
. Immunostaining against ribosomal protein S6 phosphorylated at Ser240/244 (p-rpS6)
ycin (A). Neuronal responses to leucine in primary cultures of mediobasal hypothalamic
d by 340/380 nm fluorescence ratios in primary cultures of mediobasal hypothalamic
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 19
Original Articlehypothalamic neurons sensitive to glucose and oleic-acid [Beall, 2013
#1097] [34]. Therefore, we tested the role of this pathway in leucine-
induced neuronal activation using a set of complementary approaches.
We reasoned that leucine, via its catabolism to alpha-ketoisocaproic
acid (KIC), promotes the production of TCA cycle intermediates,
eventually leading to increases in intracellular ATP levels, decreases in
intracellular MgADP levels, and potential closure of KATP channels
which could contribute to leucine-induced neuronal activation.
We first tested the effect of KIC, leucine’s first catabolite, on neuronal
activation in our preparation. Treatment with isomolar concentrations
of KIC produced an increase in [Ca2þ]i in only 4% of neurons, and a
decrease in [Ca2þ]i in only 3% of neurons (Figure 4A), indicating that
leucine’s metabolite KIC cannot replicate leucine’s rapid effects on
hypothalamic neuronal activity.
We then used the KATP channel blocker tolbutamide and the KATP
channel opener diazoxide to directly interrogate the role of KATP
channels in MBH leucine sensing. Tolbutamide blocks hypothalamic
KATP channels at doses of 100 mM and above [35,36]. Pre-treatment
with 500 mM Tolbutamide produced an increase in [Ca2þ]i
compared to [Ca2þ]i during the baseline aCSF exposure period in 18%
of the total neuronal population in culture and 19% of POMC neurons
(Figure 4BeD). This result is consistent with previous findings indi-
cating that 20% of MBH neurons express KATP channels [30]. During
co-administration of leucine and tolbutamide in the next 10 min of the
recording session, 16% of cells exhibited an increased [Ca2þ]i
compared with levels recorded during the tolbutamide only exposure
(Figure 4B,E). Only 2% of cells responded to both tolbutamide and
leucine (Figure 4G). Under these conditions, 25% of POMC neurons
were activated by leucine (Figure 4C) but none of the leucine-activated0
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indicate that a majority of leucine-activated cells have no functional
KATP currents, and closure of KATP channels does not alter the ability of
MBH neurons to rapidly sense leucine. We then tested the effect of the
KATP channel opener diazoxide. At concentrations around 300/400 mM,
diazoxide hyperpolarizes cells expressing KATP channels within 2 min
[37,38]. Co-administration of 340 mM diazoxide with leucine failed to
abrogate leucine-induced changes in [Ca2þ]i (Figure 4H,I). Collectively,
these data indicate that leucine intracellular metabolism and closure of
KATP channels do not account for the rapid sensing of leucine by MBH
neurons.
3.6. Extracellular leucine sensing mediates rapid leucine detection
by MBH neurons
Leucine is transported across the cell membrane principally via system
L amino acid transporters LAT1 (slc7a5) and LAT2 (slc7a8) [39], both
expressed in hypothalamic POMC and AGRP neurons [40]. We tested
the role of system L transporter in MBH leucine sensing using
2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH), a well-
characterized inhibitor of system L amino acid transporters [41].
BCH is a non-metabolizable analogue of Leucine that saturates all
members of LAT family at 10 mM. Of note, in pancreatic beta-cells,
BCH stimulates insulin secretion via activation of glutamate dehydro-
genase (GDH), anaplerosis, replenishment of TCA cycle intermediates,
ATP production and closure of KATP channels [42]. Therefore, we first
examined the effect of BCH on its own on [Ca2þ]i in our primary culture
model.
Pre-treatment with 10 mM BCH alone activated 10% of neurons in
culture (Figure 5A,B). During co-administration of leucine and BCH0 600 1200 1800 2400
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Figure 5: Leucine-induced changes in [Ca2D]i rely on extracellular leucine detection. Leucine-induced neuronal activation in the presence of BCH in primary cultures of
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showed an increase in [Ca2þ]i compared to [Ca2þ]i during the BCH only
exposure (Figure 5C). Only 1% of cells showed a response to both BCH
and leucine (Figure 5D). Likewise, inhibition of leucine transport failed
to abrogate leucine-induced inhibition of MBH neurons (Figure 5E,F).
These results indicate that leucine sensing is independent of system L
transporters and suggest that leucine may be sensed extracellularly.
3.7. Mechanistic insights into leucine-induced calcium fluxes
In neurons, calcium released from endoplasmic reticulum (ER) stores
or calcium entering the cell through voltage or ligand gated ion
channels are the principal sources that contribute to changes in
intracellular calcium concentrations in response to a ligand. We used
multiple strategies to determine which source of calcium is mobilized
by leucine to generate changes in [Ca2þ]i.
We first tested the role of intracellular calcium stores using thapsi-
gargin, an irreversible non-competitive inhibitor of the SERCA ATPase,
that pumps calcium into the endoplasmic reticulum against its con-
centration gradient, either to compensate for inward calcium leakage,
or to refill the stores after emptying in response to intracellular
signaling events [43]. Cells were pretreated with 200 nM thapsigargin
for 10 min to deplete intracellular calcium stores [43] and then treated
with leucine or vehicle in the presence of Thapsigargin. Upon exposure
to Thapsigargin, 66.4% cells showed a calcium response confirmingMOLECULAR METABOLISM 10 (2018) 14e27  2018 The Authors. Published by Elsevier GmbH. This is an
www.molecularmetabolism.comthe depletion of intracellular calcium stores (Figure 6A). After this initial
rise, baseline [Ca2þ]I remained elevated in 25% of cells, with a Fura2
340/380 ratio on average 0.4 higher than during aCSF exposure
(Figure 6A). In the presence of thapsigargin, leucine was still able to
produce an increase in [Ca2þ]i in 17% of cells (Figure 6B,C). By
contrast, leucine produced inhibition in a marginal number of cells in
the presence of Thapsigargin (Figure 6C).
We then examined the specific channels involved in the release of cal-
cium from the endoplasmic reticulum, and blocked ryanodine receptors
(RyR) with ryanodine, which binds and rapidly induces closure of RyR at
concentrations above 100 nM [44,45]. Co-application of 25 mM ryano-
dine with leucine did not significantly change the percentage of cells
activated or inhibited by leucine (Figure 6DeF). In POMC neurons, rya-
nodine also did not change the percentage of cells activated by leucine
(20% cells activated with DMSOþ Leu, n¼ 5, 21 POMC neurons; 20%
cells activated with Rya þ Leu, n ¼ 5, 26 POMC neurons). Likewise,
100 mM 2-APB, an inhibitor of IP3R [46]did not block leucine-induced
activation (Figure 6G,H), but significantly lowered the percentage of
leucine-inhibited cells (Figure 6G,I). Thus, leucine-induced neuronal
activation does not rely on RyR and IP3R channels, while leucine-induced
inhibition is mediated at least in part by a 2-APB sensitive mechanism.
Last, to test whether leucine-induced activation requires calcium entry
from across the plasma membrane, responses to leucine were
measured in cells pre-incubated with a calcium-depleted aCSF mediaopen access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 21
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Original Articlefor 5 min. Under these conditions, transmembrane calcium fluxes are
abrogated, but ER stores remain intact, as confirmed by the ability of
200 nM thapsigargin to produce a rapid transient increase in intra-
cellular calcium concentrations (Figure 6K). Upon transition to the
calcium depleted media, 30% of cells showed a brief calcium peak22 MOLECULAR METABOLISM 10 (2018) 14e27  2018 The Authors. Published by Elsevier G(Figure 6L), and 96.8% of neurons showed a rapid decrease in
intracellular calcium levels, reaching a stable lowered baseline within
5 min. However, in 25% of cells, [Ca2þ]i further decreased during the
following 10 min, reaching a nadir Fura2 340/380 ratio of 0.5e0.6
(Figure 6L). Following a 5 min treatment with a calcium depletedmbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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media, the percentage of neurons activated by leucine remained the
same (Figure 6M) but the magnitude of the calcium response was
significantly blunted (increase in Fura2 340/380 over baseline of
0.09  0.029 vs. 0.63  0.031, p < 0.01), and the remaining Ca2þ
fluxes were more transient than those measured in the presence of
extracellular calcium (Figure 6N). In POMC neurons, such a small
response to leucine during incubation with a calcium depleted media
was observed in only 4% of neurons (n ¼ 7, 23 POMC neurons). By
contrast, incubation in a calcium-depleted media abrogated all
leucine-induced neuronal inhibition.
Collectively, these data indicate that leucine-induced activation of
hypothalamic neurons principally relies on calcium entry from the
extracellular calcium pool. The mechanisms underlying leucine-
induced inhibition of hypothalamic neurons are sensitive to both
SERCA ATPase inhibition and 2-APB.
3.8. hPSC-derived hypothalamic neurons sense leucine
The studies performed in acutely dissociated mouse MBH neurons
suggested that leucine is sensed by a subset of MBH neurons that
respond by altering their activity and neuropeptide secretion to regulate
energy homeostasis. Since mice and humans show similar behavioral
responses to dietary amino acids [8], we hypothesized that human
hypothalamic neurons also show rapid responses to leucine. To test
this hypothesis, we differentiated human pluripotent stem cells into
hypothalamic neurons as previously described [26]. After at least 30
days in culture, these in vitro-derived human hypothalamic cultures
contained many neurons (7.39  0.37% of the cells in culture, n ¼ 4)
that were strongly immunopositive for POMC (Figure 7A), suggesting
they had been patterned to a BMH-like regional identity [25]. After cells
had matured at least 30 days in culture, cultures were dissociated, re-
plated, and imaged 24 h later after loading with Fura2 dye to replicate
the experimental manipulations that primary murine MBH neurons had
undergone. We found that a subset of human hypothalamic neuron
cultures responded to 500 uM leucine (n ¼ 7, 200 cells). Using
identical criteria to define leucine-activated and leucine-inhibited cells
as in experiments performed with murine culture, we found that
10.4  3.2% of hPSCs-derived hypothalamic neurons (n ¼ 6, 212
neurons) increased their [Ca2þ]i in response to leucine (Figure 7B),
producing a peak in [Ca2þ]i that was 25% greater than in vehicle
treated cells and an increase in the Fura2 340/380 AUC of 60%
(Figure 7C,D). Leucine decreased [Ca2þ]i in 15.6  7.2% of hPSCs-
derived hypothalamic neurons (n ¼ 6, 212 neurons) and produced
an average 9% decrease in the minimum Fura2 340/380 ratio and a
55% decrease in the Fura2 340/380 AUC (Figure 7EeG). These results
are similar to those observed in murine MBH neurons (Figure 2).
4. DISCUSSION
We developed a model of primary culture of dissociated mouse MBH
neurons prepared from post-weaning mice to investigate cell auton-
omous nutrient-sensing properties of mature MBH neurons. Using this
model, we found that leucine sensing is not a ubiquitous property of
MBH neurons. Instead, only a subset of MBH neurons responded to a
physiologically relevant increase in the extracellular concentration of
leucine. Leucine produced heterogeneous responses in a neuro-
chemically diverse group of MBH neurons including a subset of POMC
and NPY/AGRP neurons. Using a series of pharmacological manipu-
lations, we gained insights into the mechanisms engaged by leucine to
rapidly alter the activity of MBH neurons. Unexpectedly,MOLECULAR METABOLISM 10 (2018) 14e27  2018 The Authors. Published by Elsevier GmbH. This is an
www.molecularmetabolism.compharmacological gain- or loss-of-function of pathways previously
implicated in hypothalamic leucine sensing failed to alter the rapid
calcium responses to leucine. Instead, our data implicate activation of
plasma membrane Ca2þ channels in leucine-induced neuronal acti-
vation, and a mechanism sensitive to SERCA ATPase inhibition and 2-
APB in leucine-induced neuronal inhibition. Last, we found that a
subset of iPSC-derived human hypothalamic neurons responded to
leucine and these responses showed remarkable similarity to those
obtained in murine cultures, suggesting that the data obtained with
primary mouse neurons have direct relevance to human energy
homeostasis.
Our data confirm that ARH POMC neurons represent one of the main
MBH neuronal population activated by leucine [10,47]. Although
melanocortinergic signaling has been implicated in the feeding
response to MBH Leu, POMC neurons are unlikely to mediate the rapid
behavioral response to Leu, as optogenetic or chemogenetic activation
of ARH POMC neurons reduce food intake only hours after stimulation
[48,49]. How rapid changes in POMC neuronal excitability affect
appetite over that time frame remains to be determined. Alternatively,
this rapid leucine sensing may regulate other physiological functions
downstream of POMC-regulated neural circuits, including glucose
homeostasis. By contrast, rapid inhibition of a subset of NPY/AGRP
neurons is likely to mediate the rapid increase in first meal latency and
suppression of energy intake measured following acute leucine nano-
injection into the MBH [10], as acute inhibition of AGRP neurons rapidly
suppresses appetite in hungry mice [50e52]. Consistent with such an
effect, we show that leucine can suppress AGRP secretion from hy-
pothalamic slices of fasted mice. These results represent the first piece
of evidence showing that amino acids can rapidly inhibit one of the
most critical orexigenic neuronal population of the hypothalamus, and
provide a mechanism for the rapid inhibition of foraging behavior in
rodents following parenchymal administration of leucine into the MBH
[10]. Previous work showed that leucine can regulate AGRP mRNA
expression in GT1-7 cells, indicating that Leucine sensing may also
produce long term consequences on AGRP neuronal output [53]. Taken
together, our result showing both activation of ARH POMC neurons and
inhibition of ARH AGRP/NPY neurons are consistent with the anorectic
consequences of central leucine sensing and reveal that the multi-
modal anorectic behavioral response to MBH leucine exposure (i.e.
increased first meal latency, decreased meal size, decreased meal
frequency over 24 h) is mediated via the modulation of the activity of
multiple neuronal populations and downstream neural circuits.
One of the key findings of our study is that pathways previously impli-
cated in hypothalamic leucine sensing e mTORC1 signaling, leucine
decarboxylation, and KATP channels e are not required for the rapid
changes in intracellular Ca2þ concentrations of MBH neurons in
response to leucine. Consistent with these results, genetic models
developed so far to target these pathways failed to produce convincing
evidence implicating them in long-term body weight control [47,54].
Additional evidence clearly indicates that leucine can signal indepen-
dently of mTORC1 to alter the activity of hypothalamic neurons. Lack of
themTORC1 effector rpS6k1 in POMC neurons failed abrogate the ability
of ARH POMC neurons to depolarize in response to leucine [47], and
rapamycin failed suppress the effect of hypothalamic leucine on hepatic
glucose output [55]. Our data suggest that activation of mTORC1
signaling may not be essential for the rapid appetitive and consumma-
tory inhibitory behavioral responses to hypothalamic leucine. This does
not preclude a role for mTORC1 signaling in the control of food intake, as
rapamycin can rapidly produce hunger in sated animals [55,56].open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 23
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to 500 mM leucine exposure. Data are mean  SEM. *: p < 0.05. **: p < 0.01. ***: p < 0.001.
Original ArticleLeucine has been proposed to signal in the hypothalamus in part via
products of its metabolism feeding into the TCA cycle and leading to
ATP production and modulation of the activity of KATP channels [10,55].
Our results indicate that rapid leucine sensing by MBH neurons does
not require leucine catabolism, as leucine’s ketoacid did not modulate
Ca2þ concentrations of MBH neurons in culture. This observation is
consistent with the lack of an acute anorectic response to parenchymal
KIC administration in rodents [10]. In addition, we show that functional
KATP channels are not required for the rapid response to leucine. In fact,
our data indicate that most leucine sensing neurons do not respond to
tolbutamine, diazoxide, or BCH, and thus, do not appear to have
functional KATP currents. Although diazoxide has been shown to rapidly
open KATP channels [57,58] the paradigm we used in this particular24 MOLECULAR METABOLISM 10 (2018) 14e27  2018 The Authors. Published by Elsevier Gexperiment with simultaneous exposure to diazoxide and leucine does
not allow us to make strong conclusions. However, together with the
results of the other approaches we used, we can conclude that leucine-
induced activation does not require functional KATP channels, and that
metabolic sensing neurons relying on the modulation of the activity KATP
channels do not markedly overlap with the neuronal populations that
rapidly sense changes in leucine concentrations. This conclusion raises
the question of the potential segregation between leucine and glucose
sensing neurons, and supports the idea that leucine-sensing neurons
represent a neuronal population distinct from the glucose-sensing
neurons that have functional and glucose-sensitive KATP channels.
Instead, our findings suggest that neuronal leucine sensing requires
Ca2þ influx through the plasma membrane, as responses were severelymbH. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
www.molecularmetabolism.com
abrogated in Ca2þ depleted media. Leucine-induced activation appeared
to be insensitive to manipulations of ER calcium stores, as shown by the
lack of effect of thapsigargin, ryanodine and 2-APB pretreatment on
leucine-induced calcium elevations. The insensitivity to 2-APB also ex-
cludes a possible contribution of TRPC channels that open upon calcium
release from intracellular stores [59], but are 2-APB sensitive. These
results also support the conclusion that leucine is sensed extracellularly,
at least in leucine-activated neurons. Consistent with this conclusion, we
showed that rapid neuronal leucine sensing is independent of system L
transporters. However, other transporters mediate the uptake of leucine
into neurons, in particular slc6a15, slc6a16 and slc6a17 [60,61],
expressed in mouse neurons [Zhang, 2014 #1096]. BCH can potently
inhibit slc6a15 (85% inhibition with 10 mM BCH) [61,62], but the effects
of BCH on slc6a16 and slc6a17 have not been characterized.
Our data do not allow us to draw strong conclusions about the
mechanisms underlying leucine-induced inhibition. The sensitivity of
leucine-induced inhibition to both thapsigargin and 2-APB raises the
possibility that leucine-inhibited neurons have a constitutive leaking
inward calcium current responsive to depletion of ER calcium stores.
This is supported by the ability of thapsigargin to increase baseline
[Ca2þ]i in 30% of cells, and the inability of 24% of cells to maintain a
stable baseline [Ca2þ]i when exposed to a calcium-depleted media.
This calcium leak could come from a store-operated calcium channel,
and a conclusion consistent with all our observation would be that in
leucine-inhibited neurons, leucine either directly or indirectly inhibits a
store operated calcium current, leading to decreased [Ca2þ]i. This
hypothesis will have to be directly tested in the future. Of note, the
mechanisms underlying glucose-induced neuronal inhibition are also
not clarified and are still under debate.
Recently, hypothalamic tanycytes were shown to sense amino acids
from the ventricular compartment via Tas1r1/Tas1r3 and mGluR4 [63].
Here, we can exclude a contribution of these receptors that function
through G-protein mediated opening of IP3R, which we show are not
required for leucine-induced activation of hypothalamic neurons.
5. CONCLUSION
This work represents an important conceptual advance in the char-
acterization and understanding of how hypothalamic circuits sense
amino acid and protein availability. We showed that a specialized
group of MBH neurons rapidly respond to physiological changes inSummary Figure: Proposed mechanisms implicated in rapid leucine sensing in med
mediobasal hypothalamic neurons. In leucine-activated neurons (including POMC neurons)
leucine inhibits a store-operated calcium current (SOC).
MOLECULAR METABOLISM 10 (2018) 14e27  2018 The Authors. Published by Elsevier GmbH. This is an
www.molecularmetabolism.comextracellular leucine concentrations. The leucine-sensing neuronal
population of the MBH overlaps with known neurochemical populations
of this area. In addition, leucine can produce a variety of responses,
supporting the conclusions that leucine can be sensed by distinct
neural circuits via different mechanisms, to control a variety of
downstream functions. Neuronal leucine sensing in the mediobasal
hypothalamus does not rely on mTORC1 signaling, leucine metabolism
or KATP channels but requires the modulation of plasma membrane
calcium channels (Summary Figure). Future work is required to better
characterize these mechanisms and identify the unique molecular
components that make a hypothalamic neuron responsive to leucine.
Such work is critical for the future in vivo manipulation of leucine-
sensing pathways and to test their relevance to body weight control
and metabolic function.
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